Le Lézard
Classified in: Health

Weight Loss Surgery for Pakistani Youngster is a Reminder that Bariatric Medicine is Saving Lives Every Day, says Dr. Feiz & Associates

LOS ANGELES, May 17, 2019 /PRNewswire-PRWeb/ -- A May 3 article on Daily Mail UK reports that a Pakistani boy believed by his doctors to be the heaviest known youngster worldwide will soon be undergoing potentially life-saving bariatric surgery. The child, Mohammed Arbrar, is 10 years old and appears to suffer from a lifelong condition in which his appetite is virtually never satiated. The boy now weighs over 400 pounds, a weight that is considered to be life-threatening even for tall fully grown adults. Los Angeles-based weight loss clinic Dr. Feiz & Associates says that, while this is obviously a very extreme case, there appears to be real hope for the child, and it helps illustrate how bariatric surgery is now regularly saving the lives of formerly severely obese individuals.

Dr. Feiz & Associates says that for patients who are considered morbidly obese with serious health issues, weight loss surgery is sometimes the only realistic path they can take. The reason that the statistics on weight loss without surgery are so discouraging, says the clinic, is that the human body has a mechanism seemingly designed to maintain a person's typical weight, whether or not that weight is a healthy one. The weight loss clinic explains that ghrelin, often referred to as the hunger hormone, is one likely vehicle for this mechanism. It can help make it exceptionally difficult for individuals to lose large amounts of weight without rapidly gaining it back, simply because more and more ghrelin is produced as an individual starts to lose weight. Long-term dieters thus experience impossible to ignore pangs of hunger that may be similar to the drives that have plagued the unfortunate Pakistani boy. The clinic points out that the child's doctors will be performing a version of its most commonly prescribed procedure: a sleeve gastrectomy, which is becoming the gold standard in bariatric treatment due to its success in helping to quiet patients' appetites.

Dr. Feiz & Associates adds that bariatric surgery can offer patients a real opportunity for a second chance at life. Ultimately, the clinic says, bariatric surgery is not by itself a cure-all for obesity and its accompanying complications, but it does give patients some degree of feelings of hunger, and therefore the space to do the work of permanently reforming their lifelong eating habits.

Interested readers can find out more about Dr. Feiz & Associates by visiting its website at https://www.drfeiz.com/. Alternatively, the weight loss clinic can be reached by calling (310) 855-8058. Dr. Feiz & Associates is open Monday through Friday from 9:00 a.m. to 6:00 p.m.


SOURCE Dr. Feiz & Associates

These press releases may also interest you

at 05:37
According to the new market research report "Cosmetic Pigments Market by Composition (Organic, Inorganic), Type (Special Effect, Surface treated, Nano), Application (Facial Makeup, Eye Makeup, Lip Products, Nail Products, Hair Color Products), and...

at 05:31
According to a recent report by Transparency Market Research, the global Prenatal Vitamin Supplements Market is expected to witness a substantial growth during the forecast period of 2016 to 2024. The growth of the market is the result of rising...

at 05:00
The Right Step names DeLisa Duncan Russell, LSW, LPC-S, as executive director of its Houston addiction treatment center. Russell has a long career working with complex addiction issues within the military, the religious community and in private...

at 04:52
BioInvent International AB's (publ) (OMXS: BINV) partner Oxurion NV has today reported topline data from a Phase lla study evaluating THR-317, a humanized antibody against placental growth factor (PlGF), in combination with anti-VEGF (ranibizumab),...

at 04:00
NanoValent Pharmaceuticals, Inc., a development stage cancer focused pharmaceutical company progressing a new class of therapeutic agents called targeted nanospheres (TNS), today announced the acceptance and formal publication of United States Patent...

at 04:00
STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapeutics modulating RNA epigenetics, today announced that it will be hosting an international conference focused on the emerging field of "RNA epigenetics"....

News published on 17 may 2019 at 22:00 and distributed by: